31.05.2013
- After more than 12 years of service in the Brenntag Management Team and strong contribution to Brenntag Group, Peter Staartjes, President and CEO of Brenntag Latin America, has...
23.05.2013
- Forest Laboratories said on Thursday that Howard Solomon, who has led the biotech firm since 1977, will retire as chief executive officer at the end of this year and the company...
21.05.2013
- Royal Dutch/Shell CEO Peter Voser may be making his last appearance on the podium at the company's annual shareholder meeting on Tuesday, turning the spotlight on management's...
07.05.2013
- A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new...
02.05.2013
- Royal Dutch/Shell's 54-year old chief executive Peter Voser is to retire next year in a surprise early departure he said was driven by a desire for a change of lifestyle. Voser has...
24.04.2013
- Novartis has promoted Harry Kirsch, who has driven productivity improvements at its pharmaceuticals division, to be chief financial officer as the Swiss drugmaker looks to grow...
18.04.2013
- Actelion shareholders rejected a $5.6 million pay award for the biotechnology company's chief executive Jean-Paul Clozel on Thursday, making it the second Swiss company in as many...
18.04.2013
- There will be a change in management at three of the 14 business units of specialty chemicals company Lanxess. Dr. Ron Commander (62), Head of the Butyl Rubber business unit (BTR)...
